ATE184197T1 - Cyclische amp-derivate enthaltende salben - Google Patents

Cyclische amp-derivate enthaltende salben

Info

Publication number
ATE184197T1
ATE184197T1 AT93101211T AT93101211T ATE184197T1 AT E184197 T1 ATE184197 T1 AT E184197T1 AT 93101211 T AT93101211 T AT 93101211T AT 93101211 T AT93101211 T AT 93101211T AT E184197 T1 ATE184197 T1 AT E184197T1
Authority
AT
Austria
Prior art keywords
containing cyclic
cyclic amp
ointments containing
ointment
amp derivatives
Prior art date
Application number
AT93101211T
Other languages
English (en)
Inventor
Norio Takasugi
Eiichi Mafune
Masayuki Takahashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE184197T1 publication Critical patent/ATE184197T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT93101211T 1992-01-27 1993-01-27 Cyclische amp-derivate enthaltende salben ATE184197T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1154592 1992-01-27

Publications (1)

Publication Number Publication Date
ATE184197T1 true ATE184197T1 (de) 1999-09-15

Family

ID=11780936

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93101211T ATE184197T1 (de) 1992-01-27 1993-01-27 Cyclische amp-derivate enthaltende salben

Country Status (12)

Country Link
US (1) US5599798A (de)
EP (1) EP0553790B1 (de)
JP (1) JP3577091B2 (de)
KR (1) KR100227952B1 (de)
AT (1) ATE184197T1 (de)
AU (1) AU657033B2 (de)
CA (1) CA2088127A1 (de)
DE (1) DE69326266T2 (de)
DK (1) DK0553790T3 (de)
ES (1) ES2137199T3 (de)
GR (1) GR3032031T3 (de)
TW (1) TW238250B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043702A1 (en) * 1999-12-15 2001-06-21 Kyowa Hakko Kogyo Co., Ltd. Stabilizers for l-ascorbic acid-2-sodium phosphate
NL1015288C2 (nl) * 2000-05-24 2001-12-14 Peter Ferdinand Elbers Preparaat voor het stabiliseren van de beschermlaag op het epitheel van het hoornvlies of de longblaasjes.
US8927521B2 (en) 2008-11-10 2015-01-06 University of Pittsburgh—of the Commonwealth System of Higher Education Cyclic adenosine monophosphates for reducing the formation of adhesions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
US4211770A (en) * 1973-01-16 1980-07-08 The Upjohn Company Treatment of psoriasis intralesionally with N6 -2'-O-dibutyryl cyclic AMP
FR2358155A1 (fr) * 1976-07-15 1978-02-10 Lapinet Eugene Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
US4369181A (en) * 1981-08-05 1983-01-18 Sri International Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
DE3786714T2 (de) * 1986-06-16 1994-03-10 Daiichi Seiyaku Co Therapeutisches Mittel für Hautgeschwüre.
CA1322957C (en) * 1988-03-30 1993-10-12 Hitoshi Yamauchi Cyclic amp derivative ointments

Also Published As

Publication number Publication date
JP3577091B2 (ja) 2004-10-13
CA2088127A1 (en) 1993-07-28
ES2137199T3 (es) 1999-12-16
DK0553790T3 (da) 1999-12-20
DE69326266D1 (de) 1999-10-14
EP0553790B1 (de) 1999-09-08
AU657033B2 (en) 1995-02-23
JPH05271080A (ja) 1993-10-19
KR930016101A (ko) 1993-08-26
TW238250B (de) 1995-01-11
US5599798A (en) 1997-02-04
KR100227952B1 (ko) 1999-11-01
DE69326266T2 (de) 2000-05-11
EP0553790A1 (de) 1993-08-04
GR3032031T3 (en) 2000-03-31
AU3202393A (en) 1993-07-29

Similar Documents

Publication Publication Date Title
ES2104605T3 (es) Composiciones estables de acido ascorbico.
NO941968D0 (no) Organiske salter av N,N'-diacetylcystin
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
FI911763A7 (fi) N5-metyyli-5,6,7,8-tetrahydrofoolihapon ammoniumsuolat
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
FI911980A0 (fi) N-(3-fluor-2-fosfonylmetoxipropyl) -derivat av heterocykliska purin- och pyrimidinbaser, deras framstaellning och anvaendning.
ES2038714T3 (es) Mezclas de substancias activas fungicidas.
GR1001511B (el) Στεροειδείς συν?έσεις.
ATE184197T1 (de) Cyclische amp-derivate enthaltende salben
FI903692A7 (fi) N5, N10-metyleeni-5,6,7,8-tetrahydrofoolihapon suolat
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
ATE117313T1 (de) Stabile lösungen von rebeccamycinderivaten sowie deren herstellung.
DE59101404D1 (de) Topische Präparate.
DK10190D0 (da) 1,1-dioxo-cephem-4-carbothiolsyrederivater
DK586586D0 (da) Biologisk aktive amidderivater
IL87561A (en) 4-aminoethyl-2,3-dihydro- 2-benzimidazol and thione derivatives and pharmaceutical compositions containing the same
ES2113851T3 (es) Sales cristalinas estables y muy hidrosolubles antivirales de 2',3'-didesoxiinoxina monohidrato, 2',3'-didesoxi-2',3'-didehidrotimidina monohidrato y 2',3'-didesoxi-2'-fluoroinosina hemihidrato.
FR2577553B1 (fr) Derives de l'ergoline et leurs sels formes par addition avec des acides, et leurs applications therapeutiques
ES2133376T3 (es) Derivados de imidazol y su uso como agentes agroquimicos.
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염
IT1216103B (it) Peptidi ad attivita' farmaceutica.
BR1101026A (pt) Derivados de ácido n-(5,6,7,8-tetraidropirido[2,3-d]pirimidin-6-iletil-tienil e furilcarbonil) glutâmico
DK301288D0 (da) Stabile uracilpraeparater
FR2665362B1 (fr) Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee